Drug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targets

Affiliations

Vineet Bhandari. Front Pediatr. 2014.

. 2014 Jul 25:2:76.

doi: 10.3389/fped.2014.00076. eCollection 2014.

¹ Division of Perinatal Medicine, Department of Pediatrics, Yale University School of Medicine , New Haven, CT , USA.

No abstract available

Keywords: chronic lung disease; clinical trials; drug therapy; lung; newborn.

Comment on

Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.
McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL. McEvoy CT, et al. Ann Am Thorac Soc. 2014 Apr;11 Suppl 3(Suppl 3):S146-53. doi: 10.1513/AnnalsATS.201312-424LD. Ann Am Thorac Soc. 2014. PMID: 24754823 Free PMC article. Review.

1. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics (2006) 117(6):1901–610.1542/peds.2005-1414 - DOI - PubMed
1. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics (2009) 123(6):1562–7310.1542/peds.2008-1962 - DOI - PubMed
1. Bhandari A, Bhandari V. “New” bronchopulmonary dysplasia – a clinical review. Clin Pulm Med (2011) 18:137–4310.1097/CPM.0b013e318218a071 - DOI
1. Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics (2010) 126(2):291–710.1542/peds.2009-3456 - DOI - PubMed
1. Smith VC, Zupancic JA, McCormick MC, Croen LA, Greene J, Escobar GJ, et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr (2005) 146(4):469–7310.1016/j.jpeds.2004.12.023 - DOI - PubMed